Symbols

TRIB

Trinity Biotech·NASDAQ

--(--)

Signals Analysis

Bullish signal 0

Bearish signal 1

Consecutive Revenue Decline

Key Stats

0.0000DAY`S RANGE0.0000

0.000052 WK RANGE0.0000

Open

0.0000

Prev.Close

0.0000

%Range

Turnover

Avg Vol(4W)

Market Cap

Div.Yield

P/E(TTM)

EPS(TTM)

Beta

Free Float

Shares Outstanding

%Turnover

P/E(DYN)

P/B

BVPS

High

0.0000

Low

0.0000

52 Week High

0.0000

52 Week Low

0.0000

About TRIB

Trinity Biotech Plc

A leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets

Industry

Healthcare Equipment and Supplies

Established Date

Listing Date

10/23/1992

Exchange

NASDAQ Stock Exchange

Full-time Employees

401

Fiscal Year Ends

12-31

Website

www.trinitybiotech.com

Security Type

Depository Receipts (Ordinary Shares)

Office address

IDA Business Park, Bray, Co. Wicklow, Ireland A98 H5C8

Business

Introduction

Trinity Biotech Plc develops, purchases, manufactures and sells pharmaceutical diagnostic products for medical targeting in the clinical laboratory and diagnostic markets. Products are used to detect autoimmune, infectious and sexually transmitted diseases, diabetes, and liver and bowel disorders. The company is also an important supplier of raw materials for the life science industry. The company sells products in more than 110 countries around the world through its own marketing team and international distribution network as well as strategic partners. Sany Biotechnology is a public company, registered and opened in Ireland in 1992, and in October 1992, the company's securities completed an initial public offering in the United States. The company's headquarters is IDA Business Park, Bray, County Wicklow, Ireland. The company has expanded its product base through continuous development and mergers.

Company Financials

EPS

TRIB has released its 2024 Q4 earnings. EPS was reported at -1.24, versus the expected -0.3, missing expectations. The chart below visualizes how TRIB has performed over recent quarters, highlighting trends in earnings surprises.

Revenue & Expenses

TRIB has released its 2024 Q4 earnings report, with revenue of 15.86M, reflecting a YoY change of 18.09%, and net profit of -16.95M, showing a YoY change of -208.16%. The Sankey diagram below clearly presents TRIB's revenue sources and cost distribution.